The HRT homepage formulary labelling has been updated to make it clear when options refer to transdermal oestrogen and separate progestogen products, rather than a combined patch. The new wording helps prevent confusion and reduces the risk of prescribing errors, ensuring patients receive the correct HRT treatment.